These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

848 related items for PubMed ID: 16125959

  • 1. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, Brucek P, Maly M.
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [Abstract] [Full Text] [Related]

  • 2. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 3. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [Abstract] [Full Text] [Related]

  • 4. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS, Ozbek U, Polat B, Yalçin Y, Karaci AR, Bayindir O.
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR, Dryden PJ, O'Connor JP, Sadeghi H, Ansley DM, Merrick PM.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ, Nielsen C.
    Eur J Cardiothorac Surg; 2004 Aug 04; 26(2):311-7. PubMed ID: 15296889
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K, Zimmermann T, Kampe S, Kasper SM, Weber HJ, Geissler HJ, Mehlhorn U.
    Curr Med Res Opin; 2004 Jan 04; 20(1):121-6. PubMed ID: 14741082
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM, Jackson LR, Chatwin C, Smolich JJ.
    J Thorac Cardiovasc Surg; 2001 Sep 04; 122(3):457-63. PubMed ID: 11547294
    [Abstract] [Full Text] [Related]

  • 14. Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
    Durand M, Chavanon O, Tessier Y, Meyer C, Casez M, Bach V, Maitrasse B, Girardet P.
    J Card Surg; 2006 Sep 04; 21(1):17-21. PubMed ID: 16426342
    [Abstract] [Full Text] [Related]

  • 15. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS, White C, Gu J, Brown J, Gammie J, Pierson RN, Lee A, Connerney I, Avari T, Christenson R, Tandry U, Griffith BP.
    Ann Thorac Surg; 2006 Jan 04; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [Abstract] [Full Text] [Related]

  • 16. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O.
    J Thorac Cardiovasc Surg; 2000 Sep 04; 120(3):520-7. PubMed ID: 10962414
    [Abstract] [Full Text] [Related]

  • 17. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Yasim A, Aşik R, Atahan E.
    Anadolu Kardiyol Derg; 2005 Mar 04; 5(1):36-40. PubMed ID: 15755701
    [Abstract] [Full Text] [Related]

  • 18. Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery.
    Taghaddomi RJ, Mirzaee A, Attar AS, Shirdel A.
    J Cardiothorac Vasc Anesth; 2009 Jun 04; 23(3):312-5. PubMed ID: 19103500
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
    Caglar GS, Tasci Y, Kayikcioglu F, Haberal A.
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr 04; 137(2):227-31. PubMed ID: 17499419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.